Search
for
Sort by
Research 30 of 75
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- IMMUNOLOGICAL AND GENETIC ASPECTS OF HEREDITARY ANTIBODY DEFICIENCIES
- FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS
- Ritlecitinib: First Approval
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia
- Alopecia Areata
- Immunohistochemical study of hair follicle stem cells in regenerated hair follicles induced by Wnt10b
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Ritlecitinib in severe alopecia areata: a profile of its use
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- Modelling androgen synthesis and action during human sexual differentiation
- Alopecia
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Advancing Design Strategy of PROTACs for Cancer Therapy
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Third International Research Workshop on Alopecia Areata
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy